Valar Labs debuts AI-powered cancer care prediction tool and secures $22M | TechCrunch
Putting AI to work in the healthcare industry is a tricky business; it’s even more so in oncology, where the stakes are especially high. Biotech startup Valar Labs is aiming high but starting small with a tool that accurately predicts certain treatment outcomes, potentially saving precious time for patients. It has raised $22 million to expand to new cancers and therapies.
Every cancer is different, but many have established best practices honed over years of testing. Sometimes, however, that me...
Read more at techcrunch.com